Physician profile
Soram Khalsa
NPI 1649375494
$291.18
in general payments reported to CMS, 2019-2025
8 companies · $50.66 in 2025
The $50.66 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9.47 · 2020: $13.89 · 2022: $57.43 · 2023: $60.56 · 2024: $99.17 · 2025: $50.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $210.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $71.32 | 2020-2022 | |
| Heartflow, INC. | $66.92 | 2024-2025 | |
| Amgen INC. | $52.50 | 2023-2024 | Krystexxa, Repatha |
| Novo Nordisk INC | $24.93 | 2024 | Wegovy |
| Mylan Specialty L.P. | $24.89 | 2024 | Yupelri |
| Edwards Lifesciences Corporation | $21.85 | 2023 | Sapien 3 Ultra Resilia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.30 | 2023 | Ofev |
| Romark Laboratories, Lc | $9.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soram Khalsa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.